SCHEMBL15664778

SCHEMBL15664778

CCCCCCCCCCCCCCCCCC[C@H](C)[C@H](CCCCCCCCCCCCCCBr)OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.37
FAAH O00519 4/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
OPRM1 P35372 1/20 0.34
SMPD1 P17405 3/20 0.34
PTPN1 P18031 1/20 0.34
SPHK1 Q9NYA1 1/20 0.33
LMNA P02545 3/20 0.32
LCK P06239 1/20 0.32
PPARD Q03181 1/20 0.32
ZDHHC20 Q5W0Z9 1/20 0.32
ZDHHC2 Q9UIJ5 1/20 0.32
ADH1B P00325 1/20 0.32
ADH1C P00326 1/20 0.32
ADH1A P07327 1/20 0.32
ADH4 P08319 1/20 0.32
ADH7 P40394 1/20 0.32
PLA2G1B P04054 1/20 0.32
PLA2G2A P14555 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16056678 0.88 DNM1 (0.41) ZDHHC7OPRM1SMPD1PTPN1SPHK1
SCHEMBL14339562 0.82 OPRM1 (0.41) ZDHHC7OPRM1SMPD1PTPN1SPHK1
SCHEMBL14733283 0.78 LMNA (0.49) ZDHHC7FAAHLMNA
SCHEMBL14733284 0.78 LMNA (0.49) ZDHHC7FAAHLMNA
SCHEMBL13737406 0.77 TSHR (0.53) ZDHHC7FAAHSMPD1PTPN1ADH1B
SCHEMBL1659278 0.77 OPRM1 (0.41) ZDHHC7OPRM1SMPD1PTPN1SPHK1
SCHEMBL27142176 0.77 OPRM1 (0.37) ZDHHC7OPRM1SMPD1PTPN1SPHK1
SCHEMBL6470973 0.77 OPRM1 (0.37) ZDHHC7OPRM1SMPD1PTPN1SPHK1
SCHEMBL1657370 0.77 LMNA (0.48) ZDHHC7OPRM1SMPD1PTPN1SPHK1
SCHEMBL13962830 0.76 OPRM1 (0.42) ZDHHC7FAAHCNR1CNR2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9945852-B2 Method for determining the presence or absence of a biomarker ARCIS BIOTECHNOLOGY HOLDINGS LIMITED (GB) 2018-04-17 US disclosed
EP-2705367-B1 METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER BANGOR UNIV (GB) 2017-04-26 EP disclosed
US-20140127709-A1 METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER BANGOR UNIVERSITY (GB) 2014-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140127709-A1 METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF A BIOMARKER CA14, CD63, CA12 ZDHHC7 2947/4885FAAH 4244/4885CNR1 3829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.